What Happened?
Cambridge, MA-based Merus Appointed Patrick Corr as Director, Financial Planning and Analysis
About the Company
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
About the Person
Patrick Corr is Director, Financial Planning and Analysis at Merus. Previously, Patrick held various senior HR leadership roles in the industry.
Info Source
News
Short Profile